When a suspicious lesion is detected in mammography screening, the woman is recalled for further assessment.
The aim is to minimise the need for surgical removal of non-clinically relevant lesions and, at the same time, to minimise the risk of missing a clinically relevant lesion.
Test for women recalled due to suspicious lesions
The ECIBC's Guidelines Development Group (GDG) suggests using digital breast tomosynthesis (DBT) over diagnostic mammography projections in women at average risk for breast cancer recalled for suspicious lesions at mammography screening (conditional recommendation, moderate certainty of the test accuracy data).
How to obtain a sample of a suspicious breast lesion
In women with suspicious breast lesions (including mass lesions, asymmetric breast density, calcifications and/or architectural distortions) in mammography, the ECIBC's Guidelines Development Group (GDG) recommends needle core biopsy over fine needle aspiration cytology to diagnose breast cancer
(strong recommendation, moderate certainty of the evidence).
Type of guidance for needle core biopsy in individuals with breast calcifications
In individuals presenting with breast calcifications, the ECIBC´s Guidelines Development Group recommends the use of stereotactic-guided needle core biopsy over ultrasound-guided needle core biopsy to diagnose the presence of breast cancer (strong recommendation, low certainty of the evidence).
Use of clip-marking
The ECIBC's Guidelines Development Group suggests using clip-marking after needle core biopsy (NCB)/vacuum assisted needle core biopsy (VANCB) for surgical therapy planning in patients with breast cancer lesions (conditional recommendation, very low certainty of the evidence).